(Q41121441)

English

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

scientific article published on 15 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects (English)

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Joachim Stangier

1

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

Karin Rathgen

2

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

Hildegard Stähle

3

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

Dietmar Gansser

4

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

Willy Roth

5

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

language of work or name

0 references

publication date

15 May 2007

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

64

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

292-303

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

New blood thinner offers first potential alternative in 50 years: ximelagatran

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Orally active direct thrombin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Management of venous thromboembolism: past, present, and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Clinical monitoring of hirudin and direct thrombin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis program.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

27 September 2017

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

19 August 2018

Monitoring of anticoagulant effects of direct thrombin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000643

19 August 2018

Combined administration of aspirin and a specific thrombin inhibitor in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology and drug safety: lessons from hirudin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory assessment of antithrombotic therapy: what tests and if so why?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17506785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2007.02899.X

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

27 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41121441&oldid=2143929492"